Common Contracts
5 similar Underwriting Agreement contracts by Larimar Therapeutics, Inc., Oak Street Health, Inc., Onconova Therapeutics, Inc., others
UNDERWRITING AGREEMENT TACTILE SYSTEMS TECHNOLOGY, INC. 2,500,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • February 28th, 2023 • Tactile Systems Technology Inc • Surgical & medical instruments & apparatus • New York
Tactile Systems Technology, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to you, the underwriter listed in Schedule 1 hereto (the “Underwriter”), an aggregate of 2,500,000 shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriter, up to an additional 375,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
22,225,000 Shares of Common Stock LARIMAR THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 14th, 2022 • Larimar Therapeutics, Inc. • Pharmaceutical preparations • New York
Larimar Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 22,225,000 shares (the “Firm Shares”) of its common stock, par value $0.001 per share (the “Common Stock”). The Company also proposes to issue and sell to the several Underwriters up to an additional 3,333,750 shares (the “Additional Shares”) of Common Stock at the option of the Underwriters, solely to cover over-allotments, as provided in Section 2(c) below. The Firm Shares and any Additional Shares purchased by the Underwriters are referred to herein as the “Shares.” Guggenheim Securities, LLC (“Guggenheim Securities”) is acting as representative (the “Representative”) of the several Underwriters in connection with the offering and sale of the Shares contemplated herein (the “Offering”).
Option Care Health, Inc. 9,200,000 Shares of Common Stock, par value $0.0001 per share Underwriting AgreementUnderwriting Agreement • September 9th, 2021 • Option Care Health, Inc. • Services-home health care services • New York
HC Group Holdings I, LLC (the “Selling Stockholder”), a stockholder of Option Care Health, Inc., a Delaware corporation (the “Company”), proposes to sell to the underwriters set forth on Schedule 1 hereto (the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 12 hereof, and to the extent there is only a single underwriter, the term “Underwriters” shall be deemed to refer to the single Underwriter, mutatis mutandis), an aggregate of 9,200,000 shares of common stock, par value $0.0001 per share, of the Company (the “Shares”). The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
Common Stock ONCONOVA THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 12th, 2021 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • New York
Guggenheim Securities, LLC As Representative of the several Underwriters named in Schedule I attached hereto c/o Guggenheim Securities, LLC 330 Madison Avenue New York, New York 10017
Oak Street Health, Inc. [●] Shares of Common Stock Underwriting AgreementUnderwriting Agreement • November 30th, 2020 • Oak Street Health, Inc. • Services-health services • New York
EGC – Testing the waters authorization (to be delivered by the issuer to J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, and Morgan Stanley & Co. LLC in email or letter form)
